Prenetics Global Limited (NASDAQ: PRE), a health sciences company whose wellness brand IM8 is co-founded with soccer icon David Beckham, has abandoned its Bitcoin accumulation strategy just months after raising significant capital partly for that purpose.
In a December 30, 2025, announcement, the Nasdaq-listed firm revealed it halted daily Bitcoin purchases on December 4 and, with board approval, will cease all future acquisitions of the cryptocurrency.
Resources will now be channeled into accelerating the growth of IM8, described as the fast-growing supplement brand, having surpassed $100 million in annualized recurring revenue in only 11 months since launch.
CEO Danny Yeung emphasized the pivot:
“IM8’s performance has outpaced even our optimistic projections. By concentrating fully on this opportunity, we aim to drive substantial long-term value for shareholders.”
The company projects IM8 revenues of $180–200 million for fiscal year 2026, supported by investments in product development, marketing, talent, and global expansion.
Prenetics claims that it remains financially solid, holding over $70 million in cash equivalents, zero debt, and its current 510 BTC as a long-term treasury reserve—valued at roughly $45 million at recent prices. No further capital, existing or new, will go toward expanding the Bitcoin position.
The reversal follows an October equity raise of approximately $44–48 million in an oversubscribed round, which funded both Bitcoin buys and IM8 scaling.
Participants included crypto platforms like Kraken and Exodus, as well as investors tied to mining professional Jihan Wu. At that time, Bitcoin traded near $114,000, enabling purchases at elevated levels.
By late December 2025, however, the price had declined to around $88,000 amid broader market cooling.
IM8, also endorsed by tennis star Aryna Sabalenka, centers on science-backed nutrition. Its flagship Daily Ultimate Essentials product consolidates multiple supplements into one allergen-free, vegan powder drink, certified for sport use.
This strategic refocus highlights Prenetics’ confidence in consumer health over volatile digital assets, prioritizing operational execution in a high-margin wellness sector amid cryptocurrency uncertainty.
Interestingly, Prenetics and other companies appear to be shifting business strategies rather quickly without giving much thought to how these initiatives will play out in the long-term. Of course, there is no guarantee that this current pivot will pay off in the future and it remains quite unclear as to how the company plans its business operations in 2026 and beyond.
